Market Introduction
Typhoid is an infectious disease caused by Salmonella Typhi, through ingestion of contaminated food and water. This intense illness is identified by prolonged fever, headache and nausea, loss of appetite and constipation or sometimes diarrhea. Increasing threats of typhoid and growing threats of drug resistance has helped typhoid vaccines to boost its market especially among rural and hard-to-reach communities where progress in medical services, infrastructure and development may be slow.
Market Overview and Dynamics
The Middle East and Africa typhoid fever vaccines market is expected to reach US$ US$ 37.09 million in 2027 from US$ 20.00 million in 2019. The market is estimated to grow with a CAGR of 8.3% from 2020-2027. Factors such as growing initiatives for typhoid fever in Middle East and Africa region and the key factor contributing to the growth of the market. On the other hand, the market is likely to have negative impact due to risk of associated with typhoid fever vaccines.
Key Market Segments
On the basis of vaccine type, the typhoid fever vaccines market has been segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR in the market during the forecast period. Global typhoid fever vaccines market based on route of administration is segmented into oral and injectable. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR in the market during the forecast period
Major Sources and Companies Listed
Some of the major secondary sources for Middle East and Africa typhoid fever vaccines market included in the report are, Severe Typhoid Fever in Africa (SETA), Gavi - the Vaccine Alliance, International Trade Administration, World Health Organization and others.
Reasons to buy the report
Middle East and Africa Typhoid Fever Vaccines Market
By Vaccine Type
By Route of Administration
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 20.00 Million |
| Market Size by 2027 | US$ US$ 37.09 Million |
| CAGR (2020 - 2027) | 8.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Vaccine Type
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Typhoid Fever Vaccines Market is valued at US$ 20.00 Million in 2019, it is projected to reach US$ US$ 37.09 Million by 2027.
As per our report Middle East and Africa Typhoid Fever Vaccines Market, the market size is valued at US$ 20.00 Million in 2019, projecting it to reach US$ US$ 37.09 Million by 2027. This translates to a CAGR of approximately 8.3% during the forecast period.
The Middle East and Africa Typhoid Fever Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Typhoid Fever Vaccines Market report:
The Middle East and Africa Typhoid Fever Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Typhoid Fever Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Typhoid Fever Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Typhoid Fever Vaccines Market
